Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)
Clinical trial NCT05113849 · UNKNOWN
Trial details
- NCT number
- NCT05113849
- Sponsor
- HK inno.N Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2023-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.